Peter Bjerre Toft

Medicine & Life Sciences

1. Eye 100%
2. Melanoma 55%
3. Conjunctiva 52%
4. Eyelids 52%
5. Orbital Fractures 46%
6. Lacrimal Apparatus 42%
7. Myocutaneous Flap 40%
8. Orbital Implants 40%
9. Amputation 37%
10. Diplopia 37%
11. Aplasia Cutis Congenita with Epibulbar Dermoids 35%
12. Lymphoma 32%
13. Denmark 31%
14. Encephalocraniocutaneous lipomatosis 30%
15. Transplants 30%
16. Mutation 29%
17. Hard Palate 28%
18. MicroRNAs 27%
19. Neoplasms 26%
20. Plexiform Neurofibroma 24%
21. Graves Ophthalmopathy 24%
22. filaggrin 23%
23. Phantom Limb 23%
24. Retrospective Studies 23%
25. Oxyphilic Adenoma 22%
26. Lymphoma, Large B-Cell, Diffuse 22%
27. Medical Students 22%
28. Rituximab 21%
29. procollagen Type III-N-terminal peptide 21%
30. Primitive Neuroectodermal Tumors 21%
31. Ophthalmoscopy 20%
32. Marginal Zone B-Cell Lymphoma 20%
33. Oral Diagnosis 20%
34. Incidence 20%
35. Granulomatosis with Polyangiitis 20%
36. Optic Nerve Diseases 20%
37. Skin 20%
38. Neurofibromatosis 1 19%
39. Recurrence 19%
40. Collagen Type III 19%
41. Eye Diseases 18%
42. Neoplasm Metastasis 18%
43. Lacerations 18%
44. Hallucinations 18%
45. Optic Nerve 18%
46. Mucous Membrane 17%
47. Visual Cortex 17%
48. Atopic Dermatitis 16%
49. Limbus Corneae 16%
50. Gray Matter 16%